Norman T R, Fulton A, Burrows G D, Maguire K P
Eur J Clin Pharmacol. 1981;21(3):229-33. doi: 10.1007/BF00627925.
The pharmacokinetics of N-desmethyldiazepam was evaluated after oral administration of clorazepate 20 mg to 12 healthy male volunteers (6 smokers; 6 non-smokers), aged 23-29 years. Plasma levels of desmethyldiazepam were measured by gas liquid chromatography. The half life of elimination (t1/2 beta) was significantly longer in the non-smoking volunteers than in the smokers: 54.7 +17.7 versus 29.8 +9.9 h (p less than 0.05). Peak plasma concentrations (Cmax) were higher in non-smokers than in smokers, 413 +106 micrograms/l and 245 +50 micrograms/l, respectively (p less than 0.05). The sedative effect of clorazepate was less severe in smokers than in non-smokers.
对12名年龄在23 - 29岁的健康男性志愿者(6名吸烟者;6名不吸烟者)口服20毫克氯氮䓬后,评估了去甲西泮的药代动力学。采用气液色谱法测定血浆中去甲西泮的水平。非吸烟志愿者的消除半衰期(t1/2β)显著长于吸烟者:分别为54.7 + 17.7小时和29.8 + 9.9小时(p < 0.05)。非吸烟者的血浆峰值浓度(Cmax)高于吸烟者,分别为413 + 106微克/升和245 + 50微克/升(p < 0.05)。氯氮䓬对吸烟者的镇静作用比对不吸烟者的作用轻。